Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

E.U.R.L. PHARMACIE AMASSE : revenue, balance sheet and financial ratios

E.U.R.L. PHARMACIE AMASSE is a French company founded 14 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in SEVRES (92310), this company of category PME shows in 2025 a net income negative of -30 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - E.U.R.L. PHARMACIE AMASSE (SIREN 750590929)
Indicator 2025 2024 2023 2022 2021 2020 2019 2017 2016
Revenue N/C N/C N/C N/C N/C N/C N/C N/C N/C
Net income -30 068 € -92 020 € 42 078 € 226 222 € 73 071 € 49 297 € 19 342 € 91 136 € 83 797 €
EBITDA N/C N/C N/C N/C N/C N/C N/C N/C N/C
Net margin N/C N/C N/C N/C N/C N/C N/C N/C N/C

Revenue and income statement

In 2025, E.U.R.L. PHARMACIE AMASSE records a net loss of 30 k€. This deficit will reduce equity on the balance sheet.

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

-30 068 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 917%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 9%. Low autonomy: the company heavily depends on external financing (banks, suppliers).

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

916.594%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

8.968%

Asset age ratio (2025) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

36.0%

Solvency indicators evolution
E.U.R.L. PHARMACIE AMASSE

Sector positioning

Debt ratio
916.59 2025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Watch

In 2025, the debt ratio of E.U.R.L. PHARMACIE AMASSE (916.59) ranks in the top 25% of the sector. This ratio measures the weight of debt relative to equity. A high ratio may indicate excessive dependence on external financing.

Financial autonomy
8.97% 2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Watch

In 2025, the financial autonomy of E.U.R.L. PHARMACIE AMASSE (9.0%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 357.48. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

357.475

Liquidity indicators evolution
E.U.R.L. PHARMACIE AMASSE

Sector positioning

Liquidity ratio
357.48 2025
2023
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Excellent

In 2025, the liquidity ratio of E.U.R.L. PHARMACIE AMASSE (357.48) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Positioning of E.U.R.L. PHARMACIE AMASSE in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare E.U.R.L. PHARMACIE AMASSE with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about E.U.R.L. PHARMACIE AMASSE

What is the revenue of E.U.R.L. PHARMACIE AMASSE ?

The revenue of E.U.R.L. PHARMACIE AMASSE is not publicly disclosed (confidential accounts filed with INPI).

Is E.U.R.L. PHARMACIE AMASSE profitable?

E.U.R.L. PHARMACIE AMASSE recorded a net loss in 2025.

Where is the headquarters of E.U.R.L. PHARMACIE AMASSE ?

The headquarters of E.U.R.L. PHARMACIE AMASSE is located in SEVRES (92310), in the department Hauts-de-Seine.

Where to find the tax return of E.U.R.L. PHARMACIE AMASSE ?

The tax return of E.U.R.L. PHARMACIE AMASSE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does E.U.R.L. PHARMACIE AMASSE operate?

E.U.R.L. PHARMACIE AMASSE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.